Alembic intros generic BactrobanAlembic's generic Bactroban provides a treatment for secondarily infected traumatic skin lesions due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes. Eagle obtains 180 days marketing exclusivity for generic VasostrictEagle Pharmaceuticals received 180 days of marketing exclusivity from the Food and Drug Administration for its recently approved generic version of Endo’s Vasostrict (vasopressin). ANI gets FDA OK for generic Mycobutin Rifabutin capsules have a market value of approximately $16.6 million, according to IQVIA. Aurobindo gets FDA OK for generic Bystolic Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA. Camber launches generic Northera in 2 new dosage strengths Camber's droxidopa capsules are now available in 100 mg, 200 mg and 300 mg strengths. FDA approves Novadoz Pharmaceuticals' generic Gabitril, MSN's manufacturing facility FDA gives Novadoz permission for generic Gabitril, as well as for MSN’s new state-of-the-art manufacturing facility. Eagle receives FDA approval for generic Vasostrict Vasostrict had a market value of $786 million in 2020. Teva intros 2 generics Teva is offering generic Duexis and generic Daraprim. Natco enters agreement to acquire Dash Pharmaceuticals The acquisition of Dash Pharmaceuticals will provide additional opportunities in the United States, the company said. Sun Pharma receives FDA permission for generic AmBisome Liposome injection AmBisome Liposome for injection had a market value of approximately $136 million as of October 2021. First Previous 105 106 107 108 109 Next Last
